|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash from operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of core deposit intangible | |||||
| Amortization and accretion of premiums and discounts on investments, net | |||||
| Accretion of deferred loan fees and purchased premiums, net | |||||
| Amortization of debt issuance costs | |||||
| Change in fair value of sold loan servicing rights | |||||
| Additions to servicing rights on sold loans, net | |||||
| Provision for credit losses on loans | |||||
| Recapture of provision for credit losses on unfunded commitments | |||||
| Deferred Income Tax Expense (Benefit) | |||||
| Allocation of ESOP shares | |||||
| Share-based compensation expense | |||||
| Gain on sale of loans, net | |||||
| Loss on sale of securities available for sale, net | |||||
| Gain on extinguishment of subordinated debt | |||||
| Increase in cash surrender value of life insurance, net | |||||
| Income from death benefit on bank-owned life insurance, net | |||||
| Origination of loans held for sale | |||||
| Proceeds from loans held for sale | |||||
| Legal settlement paid | |||||
| Insurance reimbursement | |||||
| Change in assets and liabilities: | |||||
| Decrease (increase) in accrued interest receivable | |||||
| Decrease (increase) in ROU asset | |||||
| Decrease in prepaid expenses and other assets | |||||
| Decrease in accrued interest payable | |||||
| (Decrease) increase in lease liabilities | |||||
| (Decrease) increase in accrued expenses and other liabilities | |||||
| Net cash (used) provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of securities available for sale | |||||
| Proceeds from maturities, calls, and principal repayments of securities available for sale | |||||
| Proceeds from sales of securities available for sale | |||||
| Redemption (purchase) of FHLB stock | |||||
| Early surrender of bank-owned life insurance policy | |||||
| Purchase of bank-owned life insurance | |||||
| Proceeds from bank-owned life insurance death benefit | |||||
| Net decrease (increase) in loans receivable | |||||
| Purchase of premises and equipment, net | |||||
| Sale (purchase) of premises and equipment, net of amortization | |||||
| Proceeds from sale of premises and equipment | |||||
| Capital contributions to partnership investments | |||||
| Redemption of partnership investment | |||||
| Capital disbursements from partnership agreements | |||||
| Capital contributions to low-income housing tax credit partnerships | |||||
| Capital contributions to historic tax credit partnerships | |||||
| Net cash provided (used) by investing activities | |||||
| Cash flows from financing activities: | |||||
| Net (decrease) increase in deposits | |||||
| Proceeds from long-term FHLB advances | |||||
| Repayment of long-term FHLB advances | |||||
| Net decrease in short-term FHLB advances | |||||
| Redemption of subordinated debt, net | |||||
| Net increase in line of credit | |||||
| Net (decrease) increase in advances from borrowers for taxes and insurance | |||||
| Payment of dividends | |||||
| Restricted stock awards canceled | |||||
| Repurchase of common stock | |||||
| Net cash (used) provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest on deposits and borrowings | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosures of noncash investing activities: | |||||
| Change in unrealized loss on securities available for sale | |||||
| Change in unrealized loss on fair value hedge | |||||
| Cumulative adjustment to servicing right asset due to election of fair value option | |||||
| Change in unrealized (loss) gain on fair value hedge | |||||
| Cumulative effect of adoption of ASU 2016-13 Financial Instruments - Credit Losses on January 1, 2023 | |||||
| Lease liabilities arising from obtaining right-of-use assets | |||||
| Change in unrealized gain (loss) on DB Plan | |||||
| Amortization of unrecognized DB plan prior service cost | |||||
| Loan principal transferred from held-for-investment to held-for-sale | |||||
| Loan principal transferred to real estate owned and repossessed assets, net | |||||
| Lease liabilities arising from obtaining right-of-use assets | |||||
| Transfer of bank-owned life insurance proceeds to prepaid expenses and other assets due to death benefit accrued but not paid at year end | |||||
| Series A equity investment acquired upon conversion of commercial business loan | |||||
| Write-down of equity investment | |||||
| Loss on equity investment in QUIL received through Quin Ventures asset sale | |||||
Loading...